novel
coronaviru
emerg
pathogen
first
identifi
wuhan
china
late
decemb
viru
respons
ongo
outbreak
caus
sever
respiratori
ill
pneumonialik
infect
human
due
increas
number
case
china
outsid
china
declar
coronaviru
global
health
emerg
nearli
case
report
least
countri
territori
report
coronaviru
case
earli
februari
interhuman
transmiss
report
countri
includ
unit
state
neither
effect
antivir
vaccin
current
avail
treat
infect
viru
newli
emerg
pathogen
mani
question
remain
unansw
regard
viru
reservoir
pathogenesi
transmiss
much
unknown
collabor
effort
research
need
fill
knowledg
gap
new
viru
develop
proper
diagnost
tool
effect
treatment
combat
infect
recent
advanc
plant
biotechnolog
prove
plant
abil
produc
vaccin
biopharmaceut
rapidli
short
time
review
outbreak
china
need
rapid
vaccin
develop
potenti
plant
system
biopharmaceut
develop
discuss
global
health
system
consist
network
organ
includ
mani
privat
public
health
sector
oper
differ
region
global
level
develop
stringent
system
provid
effect
protect
human
emerg
reemerg
diseas
though
mortal
associ
variou
infecti
diseas
reduc
recent
year
global
life
expect
increas
mani
part
world
infecti
diseas
threat
still
remain
one
major
global
challeng
concern
even
global
health
system
often
confront
emerg
pathogen
respons
expand
array
infecti
diseas
zika
chikungunya
ebola
nipah
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
influenza
emerg
novel
coronaviru
recent
ad
list
problemat
emerg
pathogen
centuri
suspect
origin
person
expos
seafood
wet
market
wuhan
hubei
provinc
china
suggest
animaltohuman
transmiss
viru
strain
previous
unknown
report
infect
human
first
time
viru
continu
expand
rapidli
throughout
world
mani
confirm
suscept
case
identifi
wuhan
china
export
case
also
report
neighbor
countri
includ
thailand
japan
korea
taiwan
countri
includ
unit
state
canada
european
countri
prove
viru
potenti
quick
dissemin
across
border
respons
rapid
spread
viru
mani
countri
tighten
border
secur
investig
peopl
show
symptom
taken
necessari
emerg
step
control
spread
due
increas
number
case
china
countri
declar
outbreak
global
health
emerg
intern
concern
januari
coronavirus
cov
belong
famili
coronavirida
subfamili
coronavirina
order
nidoviral
classifi
four
genera
alphacoronaviru
betacoronaviru
infect
mammal
wherea
gammacoronaviru
infect
avian
speci
deltacoronaviru
infect
mammalian
avian
speci
larg
envelop
viru
posit
sens
singlestrand
rna
genom
kb
distribut
broadli
among
bird
human
mammal
camel
bat
mice
dog
cat
genom
surround
helic
capsid
envelop
spike
protein
form
larg
protrus
envelop
shape
crown
give
viru
coron
appear
word
corona
latin
mean
crown
human
coronavirus
hcov
major
group
coronavirus
known
respiratori
pathogen
associ
respiratori
intestin
infect
vari
sever
includ
common
cold
pneumonia
bronchiol
human
coronavirus
usual
caus
mild
infect
human
howev
onset
betacoronavirus
sever
acut
respiratori
syndrom
coronaviru
sarscov
outbreak
guangdong
provinc
china
middl
east
respiratori
syndrom
coronaviru
merscov
diseas
outbreak
middl
east
result
high
pathogen
human
demonstr
lethal
viru
cross
speci
barrier
anim
human
virus
believ
origin
bat
subsequ
transmit
human
hcov
evolv
rapidli
recent
year
due
mutat
high
nucleotid
substitut
rate
abil
establish
infect
new
host
crossspeci
transmiss
decemb
china
detect
mani
case
viral
pneumonialik
diseas
similar
sar
confirm
caus
novel
betacoronaviru
provision
call
novel
coronaviru
sinc
novel
coronaviru
outbreak
rais
attent
throughout
world
although
potenti
caus
diseas
still
unknown
initi
report
predict
viru
possibl
zoonot
origin
caus
agent
sever
respiratori
infect
human
term
novel
coronavirusinfect
pneumonia
ncip
ncov
third
known
coronaviru
caus
fatal
respiratori
diseas
human
highli
pathogen
virus
sarscov
merscov
chines
research
isol
novel
coronaviru
infect
patient
earli
viru
close
relat
bat
coronavirus
suspect
bat
primari
reservoir
viru
howev
still
unclear
viru
transmit
human
directli
bat
whether
intermedi
host
detail
understand
enzoot
pattern
viru
evolut
surveil
essenti
control
diseas
possibl
prevent
futur
epidem
similar
virus
explos
outbreak
china
spread
rapidli
mani
countri
probabl
human
movement
travel
geograph
distribut
viru
increas
sinc
outbreak
earli
februari
thousand
case
confirm
china
case
report
outsid
china
number
case
escal
daili
provinc
china
countri
viru
transmit
rapidli
mani
case
report
global
februari
nearli
affect
case
fatal
report
china
confirm
case
wuhan
citi
hubei
provinc
outsid
china
case
confirm
global
one
death
report
philippin
singapor
case
confirm
thailand
japan
korea
australia
malaysia
unit
state
case
report
germani
franc
vietnam
uae
canada
india
philippin
itali
uk
russia
nepal
sri
lanka
cambodia
belgium
finland
sweden
spain
earli
februari
chines
health
author
countri
respond
fast
immedi
action
taken
contain
viru
countri
implement
stringent
border
control
screen
travel
possibl
infect
travel
restrict
order
prevent
spread
rapid
spread
infect
frighten
also
caus
mortal
financi
loss
present
global
concern
emerg
diseas
transmiss
often
spread
person
person
respiratori
droplet
gener
cough
sneez
infect
person
humantohuman
transmiss
report
countri
germani
japan
vietnam
unit
state
confirm
case
interhuman
transmiss
increas
fear
panic
accompani
outbreak
still
unknown
whether
viru
spread
human
contact
possibl
transmiss
oralfec
contact
well
incub
time
vari
day
infect
clinic
present
infect
resembl
sarscov
character
fever
dri
cough
short
breath
case
wherea
nonrespiratori
symptom
headach
muscl
ach
dyspnoea
rhinorrhoea
sneez
sore
throat
diarrhea
nausea
vomit
also
report
patient
affect
person
also
develop
acut
respiratori
distress
syndrom
case
critic
ill
show
respiratori
failur
septic
shock
organ
failur
requir
intens
care
support
time
knowledg
viru
limit
new
case
mortal
increas
daili
newli
emerg
viral
infect
vaccin
antivir
therapeut
treat
human
coronaviru
infect
till
prevent
infect
current
prioriti
diseas
control
current
protocol
infect
patient
quarantin
provid
support
manag
palli
care
best
way
avoid
viru
infect
keep
oneself
away
infect
peopl
utmost
person
hygien
care
essenti
quarantin
measur
shall
taken
separ
restrict
movement
infect
peopl
also
normal
popul
region
epidem
outbreak
recommend
precautionari
measur
gener
public
frequent
clean
hand
wear
face
mask
avoid
close
contact
infect
person
farm
anim
avoid
consumpt
raw
halfcook
meategg
follow
good
food
safeti
practic
urgent
need
develop
rapid
diagnost
tool
vaccin
postexposur
prophylaxi
treat
infect
reliabl
time
laboratori
diagnosi
effect
vaccin
crucial
effect
diseas
manag
public
health
intervent
effect
vaccin
afford
also
product
platform
produc
suitabl
vaccin
candid
rapidli
low
cost
especi
diseas
outbreak
advantag
disadvantag
current
express
system
recombin
protein
product
given
tabl
current
plant
express
system
offer
mani
advantag
convent
system
potenti
tackl
product
vaccin
candid
rapidli
afford
cost
facilit
global
vaccin
program
especi
resourcepoor
nation
vaccin
need
recent
year
plant
focus
product
biopharmaceut
viruslik
particl
vlp
technolog
employ
product
plantmad
vaccin
stabl
nuclear
express
transient
express
chloroplast
express
base
sever
vital
factor
like
yield
qualiti
time
cost
appropri
technolog
chosen
produc
biopharmaceut
recent
advanc
plant
express
strategi
especi
develop
transient
express
system
viral
vector
result
huge
increas
protein
yield
make
plant
host
system
promis
system
product
variou
biopharmaceut
protein
sever
report
last
two
decad
enough
evid
prove
plant
produc
biopharmaceut
effect
mammalian
cellbas
protein
also
elicit
potent
neutral
antibodi
shown
therapeut
effect
particular
pathogen
infect
use
plant
product
recombin
protein
biopharmaceut
gain
import
sinc
plant
produc
biolog
taligluceras
alfa
commerci
gaucher
diseas
proclaim
new
era
plant
made
biopharmaceut
trigger
innov
field
biopharmaceut
furthermor
mani
plantproduc
candid
clinic
pipelin
close
commerci
exampl
plantproduc
recombin
antigen
monoclon
antibodi
infecti
diseas
given
tabl
current
countri
includ
thailand
india
japan
korea
european
commun
majorli
involv
develop
plant
biopharmaceut
sever
human
diseas
mani
report
review
import
plant
express
system
rapid
product
candid
vaccin
therapeut
antibodi
infecti
diseas
west
nile
viru
tobacco
mani
biopharmaceut
compani
shift
momentum
toward
plant
express
system
know
import
variou
plant
tobacco
duckwe
moss
alfalfa
plant
use
product
plantmad
pharmaceut
septemb
leaf
bio
inc
commerci
partner
mapp
biopharmaceut
inc
mapp
receiv
fast
track
design
us
fda
plantmad
biopharmaceut
call
zmapp
treatment
ebola
viru
diseas
author
plantbas
biopharmaceut
zmapp
emerg
use
earlier
ebv
outbreak
fda
potenti
major
breakthrough
plant
molecular
farm
field
serv
endors
technolog
potenti
investor
grant
fund
agenc
mani
vaccin
antigen
express
plant
clinic
advanc
preclin
trial
major
player
global
plantbas
biolog
market
includ
plantform
ibio
inc
mapp
biopharmaceut
inc
pfizer
inc
ventria
bioscienc
medicago
inc
greenov
biotech
gmbh
kentucki
bioprocess
phycobiolog
inc
synthon
fraunhof
ime
healthgen
planet
biotechnolog
icon
genet
gmbh
plantmad
biopharmaceut
provid
efficaci
costeffect
strategi
protect
emerg
infecti
diseas
plant
express
system
employ
develop
vaccin
ncov
transient
express
plant
adapt
biopharmaceut
protein
product
necessari
produc
rapid
respons
vaccin
produc
protein
short
time
plantbas
biopharmaceut
product
includ
identif
potenti
epitop
product
fulllength
viral
surfac
protein
present
envelop
region
product
subunit
vaccin
express
immunogen
region
chimer
protein
receptorbind
domain
rbd
spike
protein
locat
outer
membran
coronaviru
mediat
receptor
bind
play
major
role
viru
entri
host
cell
protein
could
use
potenti
vaccin
candid
major
target
neutral
antibodi
henc
could
consid
develop
potenti
effect
vaccin
therapeut
coronaviru
infect
viru
use
angiotensinconvert
enzym
host
cell
receptor
cell
entri
similar
like
sarscov
monoclon
antibodi
identifi
test
effect
sar
viru
protein
specif
produc
plant
shall
test
efficaci
ncov
earlier
report
show
sever
vaccin
monoclon
antibodi
candid
respons
sarscov
merscov
could
test
use
passiv
immunotherapi
immedi
immun
respons
possibl
produc
vlp
base
vaccin
also
feasibl
express
structur
viral
protein
assembl
vlp
plant
structur
function
studi
viral
protein
ncov
might
help
design
better
vaccin
specif
therapeut
produc
viral
protein
plant
may
help
evalu
potenti
develop
diagnost
kit
protectiontherapeut
tool
manufactur
fast
order
manag
highli
infecti
ncov
open
avenu
character
recombin
immunogen
viral
protein
provid
proof
concept
use
plant
robust
rapid
flexibl
platform
produc
proteinresearch
reagent
highli
essenti
face
potenti
ncov
outbreak
coronaviru
outbreak
declar
global
health
emerg
repres
one
greatest
risk
global
health
viru
tendenc
infect
larg
number
human
popul
outbreak
caus
sever
medic
complic
econom
impact
particularli
middleincom
countri
resourc
limit
earli
diagnosi
prevent
measur
human
mobil
air
travel
intern
trade
like
increas
number
case
region
well
continu
surveil
along
robust
respons
govern
agenc
medic
practition
research
highli
essenti
effect
manag
emerg
pathogen
public
health
offici
need
identifi
sourc
viru
reservoir
transmiss
cycl
pathogenesi
interhuman
transmiss
clinic
manifest
might
help
develop
anim
model
diagnost
reagent
antivir
therapi
vaccin
pathogen
viru
emerg
suddenli
becam
seriou
global
concern
need
rapid
vaccin
develop
although
classic
express
system
biopharmaceut
protein
still
amen
develop
transient
express
plant
deepli
influenc
pharmaceut
sector
produc
afford
vaccin
biolog
rapidli
low
cost
henc
plant
express
platform
shall
employ
biopharmaceut
product
acceler
fight
deadli
infecti
diseas
collabor
effort
research
highli
desir
use
plant
express
platform
produc
effici
costeffect
vaccin
control
epidem
continu
effort
research
direct
might
help
produc
highvalu
biolog
pharmaceut
larg
scale
short
time
especi
epidem
